Clinical trial Recruiting at 1 site Observational

Research on aging and cognitive impairment in China

Official title: A Longitudinal Study on the Aging of Health and Cognitive Impairment in China

Run by First Affiliated Hospital of Wenzhou Medical University · NCT06679296 · Data updated 2026-11-12

This study is trying to understand how health and thinking skills change as people get older in China, especially among the elderly, to help create better support and treatments for aging-related issues.

Quick facts

Study typeObservational
SexAll
Enrollment20000 (estimated)
SponsorFirst Affiliated Hospital of Wenzhou Medical University
Academic / other
Locations1 site (Wenzhou, Zhejiang)
StatusRecruiting
StartedNovember 20, 2024
Main results expectedDecember 31, 2033
Study endsDecember 31, 2033
Registry record updatedNovember 7, 2024
Trial IDNCT06679296 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study include individuals from various age groups, particularly those aged 60 and older, who can provide informed consent and complete the required assessments.

Probably not a fit

Patients with terminal diseases or substance abuse issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate health and cognitive changes across different age groups in China, focusing on the elderly population. It will recruit participants from hospitals, schools, and communities, conducting detailed medical examinations that include physiological checks, psychological assessments, and cognitive function screenings. The study seeks to establish a comprehensive database on aging and cognitive impairments, utilizing advanced omics approaches to identify biomarkers and develop personalized interventions. The ultimate goal is to support healthy aging policies and improve management strategies for aging-related diseases.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for promoting healthy aging and managing cognitive impairments in the elderly.

How similar studies have gone: Other studies focusing on aging and cognitive impairment have shown promise, but this specific approach utilizing a large cohort and advanced omics techniques is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Ability to sign an informed consent form: Participants and/or their legally authorized representatives, in case of diminished decision-making capacity, are capable of reading, understanding, and providing written informed consent as per national legal requirements.
2. Capability to complete assessments independently or with assistance.
3. Willingness and ability to fulfill all study requirements, including peripheral organ function assessments, EEG, lumbar puncture, MRI, and PET imaging examinations.
4. Agreement to participate in follow-up visits.

Exclusion Criteria:

1. Terminal stage of significant diseases such as malignant tumors or autoimmune diseases at enrollment;
2. Substance abusers.

Where it's running

  • The First Affiliated Hospital of Wenzhou Medical University
    Wenzhou, Zhejiang, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.